Treatment of Childhood Kaposiform Hemangioendothelioma With Sirolimus

被引：133

作者：

Blatt, Julie ^{[1
]}

Stavas, Joseph ^{[1
]}

Moats-Staats, Billie ^{[1
]}

Woosley, John ^{[1
]}

Morrell, Dean S. ^{[1
]}

机构：

[1] Univ N Carolina, Div Pediat Hematol Oncol, Vasc Lesions Clin, Chapel Hill, NC 27599 USA

来源：

PEDIATRIC BLOOD & CANCER | 2010年 / 55卷 / 07期

关键词：

angiogenesis; new agents; vascular malformations; MALFORMATIONS IN-VIVO; RECIPIENTS; GROWTH;

D O I：

10.1002/pbc.22766

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Sirolimus (Rapamune), a mammalian target of Rapamycin (mTOR) inhibitor, which his been used extensively in children following solid organ transplantation has been demonstrated to have anti angiogenic activity in pre clinical models Limited experience suggests that it may have application to the treatment of vascular lesions We describe our experience with a 1 year old female with a kaposiform hemangioendothelioma and Kasabach-Merritt phenomenon who had rapid and dramatic response to sirolimus (0 1 mg/kg/day) This case provides further rationale for clinical trials of sirolimus in the treatment of vascular lesions Pediatr Blood Cancer 2010 55 1396-1398 (C) 2010 Wiley Liss Inc

引用

页码：1396 / 1398

页数：3

共 15 条

[1]

Adams D M, 2001, Facial Plast Surg Clin North Am, V9, P601

[2]

Ballou Lisa M, 2008, J Chem Biol, V1, P27, DOI 10.1007/s12154-008-0003-5

[3] Pulmonary epithelioid haemangioendothelioma and bevacizumab [J].

Belmont, Laure ;

Zemoura, Leila ;

Couderc, Louis Jean .

JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (05) :557-558

[4] Oral Administration of Blueberry Inhibits Angiogenic Tumor Growth and Enhances Survival of Mice with Endothelial Cell Neoplasm [J].

Gordillo, Gayle ;

Fang, Huiqing ;

Khanna, Savita ;

Harper, Justin ;

Phillips, Gary ;

Sen, Chandan K. .

ANTIOXIDANTS & REDOX SIGNALING, 2009, 11 (01) :47-58

[5] Mediastinal Kaposiform Hemangioendothelioma and Kasabach-Merritt Phenomenon in an Infant Treatment With Interferon [J].

Hartman, Kip R. ;

Moncur, Joel T. ;

Minniti, Caterina P. ;

Creamer, Kevin M. .

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2009, 31 (09) :690-692

[6] Kaposiform hemangioendothelioma - A study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma [J].

Lyons, LL ;

North, PE ;

Lai, FMM ;

Stoler, MH ;

Folpe, AL ;

Weiss, SW .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (05) :559-568

[7] Indications, tolerance and complications of a sirolimus and calcineurin inhibitor immunosuppression regimen: Intermediate experience in pediatric heart transplantation recipients [J].

Matthews, Kathleen ;

Gossett, Jeffrey ;

Kappelle, Peter Vande ;

Jellen, Gina ;

Pahl, Elfriede .

PEDIATRIC TRANSPLANTATION, 2010, 14 (03) :402-408

[8] TREATMENT OF MURINE HEMANGIOENDOTHELIOMAS WITH THE ANGIOGENESIS INHIBITOR AGM-1470 [J].

OREILLY, MS ;

BREM, H ;

FOLKMAN, J .

JOURNAL OF PEDIATRIC SURGERY, 1995, 30 (02) :325-330

[9] AKT1 overexpression in endothelial cells leads to the development of cutaneous vascular malformations in vivo [J].

Perry, Betsy ;

Banyard, Jacqueline ;

McLaughlin, Elizabeth R. ;

Watnick, Randy ;

Sohn, Allie ;

Brindley, David N. ;

Obata, Toshiyuki ;

Cantley, Lewis C. ;

Cohen, Cynthia ;

Arbiser, Jack L. .

ARCHIVES OF DERMATOLOGY, 2007, 143 (04) :504-506

[10] Refractory Kaposiform Hemangioendothelioma That Expressed Vascular Endothelial Growth Factor Receptor (VEGFR)-2 and VEGFR-3 A Case Report [J].

Saito, Mari ;

Gunji, Yuji ;

Kashii, Yoshitumi ;

Odaka, Jun ;

Yamauchi, Tadahiko ;

Kanai, Nobuyuki ;

Momoi, Mariko Y. .

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2009, 31 (03) :194-197

← 1 2 →